# Gene Interaction and Cumulative Effect Visualization

## Introduction

This report provides visualizations of the potential interactions between SHANK2, SHANK3, CNTN4, and PTPRN2 genes, and how the identified insertions might collectively impact biological pathways and processes.


## Gene Information

### SHANK2

**Primary Function:** Postsynaptic scaffold protein

**Key Domains:** ANK repeat, SH3, PDZ, Proline-rich, SAM

**Expression Pattern:** Brain (excitatory synapses)

**Associated Conditions:** Autism spectrum disorders, intellectual disability


### SHANK3

**Primary Function:** Postsynaptic scaffold protein

**Key Domains:** ANK repeat, SH3, PDZ, Proline-rich, SAM

**Expression Pattern:** Brain (excitatory synapses)

**Associated Conditions:** Autism spectrum disorders, Phelan-McDermid syndrome


### CNTN4

**Primary Function:** Axon guidance and neural circuit formation

**Key Domains:** Ig-like, Fibronectin type III, GPI anchor

**Expression Pattern:** Developing nervous system, olfactory system

**Associated Conditions:** Neurodevelopmental disorders, autism spectrum disorders


### PTPRN2

**Primary Function:** Dense-core vesicle protein, insulin secretion

**Key Domains:** Signal peptide, Extracellular, Transmembrane, Phosphatase-like

**Expression Pattern:** Neuroendocrine cells, pancreatic beta cells, brain

**Associated Conditions:** Type 1 diabetes autoantigen, metabolic disorders


# Insertion Summary by Gene

This table summarizes the insertions found in each gene and their characteristics.


| Gene | Insertions | Homozygous | Heterozygous | Average Length | Potential Impact |

|------|------------|------------|--------------|----------------|------------------|

| SHANK2 | 1 | 1 | 0 | 474 bp | Homozygous variants, Long insertions, Synaptic organization |

| SHANK3 | 1 | 1 | 0 | 182 bp | Homozygous variants, Synaptic organization |

| CNTN4 | 4 | 2 | 2 | 263 bp | Homozygous variants, Neural circuit formation |

| PTPRN2 | 5 | 4 | 1 | 360 bp | Homozygous variants, Long insertions, Insulin signaling |




# Gene Interaction Matrix

This matrix shows the shared pathways and processes between the four genes of interest.


| Pathway/Process | SHANK2 | SHANK3 | CNTN4 | PTPRN2 |
|----------------|---------|---------|---------|---------|
| Synaptic Function | ✓ | ✓ | ✓ |   |
| Neural Development | ✓ | ✓ | ✓ | ✓ |
| Vesicle Trafficking | ✓ | ✓ |   | ✓ |
| Metabolic Signaling |   | ✓ |   | ✓ |
| Cell Adhesion |   | ✓ | ✓ |   |
| Cytoskeletal Regulation | ✓ | ✓ |   |   |
| mTOR Signaling |   | ✓ |   | ✓ |



# Shared Pathway Visualization

This diagram illustrates the shared biological pathways and processes between the four genes.


```

                   Neural Development                  
                          |                            
                          v                            
  +-------------+     +-------+     +--------------+   
  |             |     |       |     |              |   
  |   SHANK2    |<--->| CNTN4 |     |    PTPRN2    |   
  |             |     |       |     |              |   
  +------^------+     +---^---+     +------^-------+   
         |                |                |           
         |                |                |           
         v                v                v           
  +------+----------------+----------------+------+    
  |                                               |    
  |                    SHANK3                     |    
  |                                               |    
  +-----------------------------------------------+    
         |                |                |           
         v                v                v           
  Synaptic Function  Cell Adhesion  Metabolic Signaling
```




# Potential Cumulative Effects Visualization

This diagram illustrates how insertions in multiple genes might lead to cumulative effects on phenotype.


```

  GENOMIC INSERTIONS                 AFFECTED PATHWAYS                 POTENTIAL PHENOTYPIC EFFECTS  
  ------------------                 -----------------                 ----------------------------  
                                                                                                     
  +----------------+                +------------------+                                             
  | SHANK2         |--------------->| Synaptic         |                                             
  | 1 homozygous   |                | Organization     |----+                                        
  +----------------+                +------------------+    |                                        
                                                            |                                        
  +----------------+                +------------------+    |         +------------------------+     
  | SHANK3         |--------------->| Synaptic         |    +-------->| Neurological &        |     
  | 1 homozygous   |                | Plasticity       |----+         | Cognitive Function    |     
  +----------------+                +------------------+    |         +------------------------+     
                                                            |                                        
  +----------------+                +------------------+    |                                        
  | CNTN4          |--------------->| Neural Circuit   |----+                                        
  | 2 homozygous   |                | Formation        |                                             
  | 2 heterozygous |                +------------------+                                             
  +----------------+                                                                                 
                                    +------------------+              +------------------------+     
  +----------------+                | Insulin          |              | Metabolic Function &   |     
  | PTPRN2         |--------------->| Signaling        |------------->| Growth Regulation      |     
  | 4 homozygous   |                +------------------+              +------------------------+     
  | 1 heterozygous |                                                                                 
  +----------------+                +------------------+                                             
                                    | Vesicle          |                                             
                                    | Trafficking      |                                             
                                    +------------------+                                             
```




## Key Findings

1. **Multiple Affected Pathways:** The four genes participate in several shared biological pathways, suggesting potential for cumulative effects.


2. **Predominance of Homozygous Insertions:** 8 out of 11 insertions are homozygous, potentially resulting in stronger functional impacts.


3. **Synaptic Function Impact:** SHANK2, SHANK3, and CNTN4 all contribute to synaptic development and function, suggesting a potential cumulative effect on neural circuit formation and function.


4. **Metabolic-Neuronal Interface:** PTPRN2 and SHANK3 share involvement in metabolic signaling pathways, suggesting a potential link between insulin signaling and neuronal function.


5. **Potential Phenotypic Convergence:** Despite affecting different primary pathways, the cumulative effects may converge on related phenotypic outcomes in neurological function and metabolic regulation.


## Conclusion

The visualizations and analyses presented in this report highlight the interconnected nature of SHANK2, SHANK3, CNTN4, and PTPRN2 genes. The insertions identified in these genes may have cumulative effects on shared biological pathways, potentially resulting in more significant impacts than would be expected from any single gene disruption.


The predominance of homozygous insertions suggests potentially stronger functional impacts, particularly in pathways related to synaptic function, neural circuit formation, and insulin signaling. These cumulative effects may contribute to a distinctive profile of neurological, developmental, and metabolic characteristics.


Further functional studies would be valuable to validate these predicted interactions and cumulative effects, and to better understand how they may manifest phenotypically.
